Cencora IncCOR
Price$309.78Intrinsic value$291.786% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $291.78median of 6 methods · middle span $225-$504based on filings through 30 Jun 2026
Market Price $309.78Price as of 1 Oct 2026
Margin of Safety -5.8%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 12.4% (near-term consensus, capped) · years 2–5: 10.8%/yr (balance of the path).11.1% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 69.9%Yr 79.1%Yr 88.2%Yr 97.3%Yr 106.4%
10.8% → 6.4%
Years 11–20: glide to long-run rate
Per-year rates
Yr 116.1%Yr 125.7%Yr 135.4%Yr 145.0%Yr 154.7%Yr 164.4%Yr 174.0%Yr 183.7%Yr 193.3%Yr 203.0%
6.4% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 2 windows (6/7y) (limited history)6.4%
Discount rate (cost of equity) 8.1%
Volatility vs market (adjusted beta)0.71

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetCencora IncCORHealth Care
Valuation
P/E23.0×
P/S0.2×
P/B19.8×
EV / Revenue0.2×
EV / EBITDA—
Profitability
Gross margin4.0%
Operating margin0.9%
Net margin0.8%
FCF margin1.2%
Returns
ROE86.0%
ROA3.1%
ROIC21.9%
Growth
Revenue growth (YoY)13.2%
5-yr fwd EPS growth11.1%
Financial strength
Debt / Equity3.84×
Current ratio0.93×
Altman Z-Score4.6
Interest coverage—
Dividend yield0.7%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.